Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
A 2-arms randomized open prospective intervention study to determine the Growth and metabolic
response to growth hormone and gonadotropin-releasing hormone agonist treatment versus growth
hormone alone in boys born SGA.
All subjects will be treated with NorditropinSimplex at a dosage of 100mcg/kg/d.
At onset of puberty, subjects will be randomized into either combined treatment with GH and
GnRHa or GH alone.